These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22208997)

  • 1. Parathyroid hormone measurement in chronic kidney disease--an evolving issue for the nephrologist and the clinical laboratorist: minireview.
    Correale M
    Immunopharmacol Immunotoxicol; 2012 Aug; 34(4):541-7. PubMed ID: 22208997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CKD patients: the dilemma of serum PTH levels.
    Pontoriero G; Cozzolino M; Locatelli F; Brancaccio D
    Nephron Clin Pract; 2010; 116(4):c263-8. PubMed ID: 20639672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Parathormone and chronic kidney disease].
    Bacchetta J; Jolivot A; Souberbielle JC; Charrié A; Guebre F; Chauvet C; Fouque D
    Nephrol Ther; 2007 Jul; 3(4):133-8. PubMed ID: 17658439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid Hormone Fragments: New Targets for the Diagnosis and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder.
    Chen H; Han X; Cui Y; Ye Y; Purrunsing Y; Wang N
    Biomed Res Int; 2018; 2018():9619253. PubMed ID: 30627584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpretation of serum parathyroid hormone concentrations in dialysis patients: what do the KDIGO guidelines change for the clinical laboratory?
    Souberbielle JC; Cavalier E; Jean G
    Clin Chem Lab Med; 2010 Jun; 48(6):769-74. PubMed ID: 20298134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Gene therapy for secondary hyperparathyroidism].
    Kanai G; Fukagawa M
    Clin Calcium; 2010 Jul; 20(7):1052-9. PubMed ID: 20585184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in parathyroid disease and parathyroid hormone assays.
    Garon JE; Liu N
    Clin Leadersh Manag Rev; 2002; 16(3):187-91. PubMed ID: 12046277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D metabolism and activity in the parathyroid gland.
    Bienaimé F; Prié D; Friedlander G; Souberbielle JC
    Mol Cell Endocrinol; 2011 Dec; 347(1-2):30-41. PubMed ID: 21664247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Delayed measurement of PTH in patients with CKD: storage of the primary tube in the dialysis unit, which temperature? Which kind of tube?].
    Parent X; Alenabi F; Brignon P; Souberbielle JC
    Nephrol Ther; 2009 Feb; 5(1):34-40. PubMed ID: 18674975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
    Zisman AL; Hristova M; Ho LT; Sprague SM
    Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.
    Lavi-Moshayoff V; Wasserman G; Meir T; Silver J; Naveh-Many T
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F882-9. PubMed ID: 20685823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays.
    Höppner J; Jüppner H
    Curr Opin Nephrol Hypertens; 2024 Jul; 33(4):375-382. PubMed ID: 38701324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic kidney disease (CKD) and bone. Targets of serum calcium, phosphate, and parathyroid hormone levels and their controls in maintenance dialysis patients].
    Akiba T
    Clin Calcium; 2009 Apr; 19(4):537-44. PubMed ID: 19329833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative parathyroid hormone levels in thyroid and parathyroid surgery.
    Warren FM; Andersen PE; Wax MK; Cohen JI
    Laryngoscope; 2002 Oct; 112(10):1866-70. PubMed ID: 12368632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic kidney disease (CKD) and bone. Management of chronic kidney disease-mineral and bone disorder in peritoneal dialysis patients].
    Yaginuma T; Yamamoto H
    Clin Calcium; 2009 Apr; 19(4):508-13. PubMed ID: 19329829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic regulation of circulating PTH: significance in health and in disease.
    D'Amour P
    Clin Biochem; 2012 Aug; 45(12):964-9. PubMed ID: 22569597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium homeostasis: reassessment of the actions of parathyroid hormone.
    Talmage RV; Mobley HT
    Gen Comp Endocrinol; 2008 Mar; 156(1):1-8. PubMed ID: 18160068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to mineral and bone disorder clinical practice guidelines in chronic kidney disease.
    Panawong W; Chaiyakum A; Pongskul C
    J Med Assoc Thai; 2011 Oct; 94(10):1175-83. PubMed ID: 22145501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.